Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meropenem-FL058 in Complicated Urinary Tract Infections
NCT05060419Phase 2Unknown
- Sponsor
- Qilu Pharmaceutical
- Start
- Oct 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of pralubactam in complicated urinary tract infection (cUTI), acute pyelonephritis, sponsored by Qilu Pharmaceutical. Status: unknown.
02
Drugs
pralubactam
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on NCT05060419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05060419.